webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

N-(2-(2-Fluorophenoxy)ethyl)-4-Formylbenzamide

  CAS No.: 1225705-45-2   Cat No.: BADC-00533 4.5  

N-(2-(2-Fluorophenoxy)ethyl)-4-Formylbenzamide is a fluorophenoxy-containing aldehyde ADC linker optimized for selective bioorthogonal antibody conjugation, enhancing payload attachment and therapeutic efficacy in ADCs.

N-(2-(2-Fluorophenoxy)ethyl)-4-Formylbenzamide

Structure of 1225705-45-2

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Linker
Molecular Formula
C16H14FNO3
Molecular Weight
287.29
Shipping
Room temperature

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
IUPAC Name
N-[2-(2-fluorophenoxy)ethyl]-4-formylbenzamide
Canonical SMILES
C1=CC=C(C(=C1)OCCNC(=O)C2=CC=C(C=C2)C=O)F
InChI
InChI=1S/C16H14FNO3/c17-14-3-1-2-4-15(14)21-10-9-18-16(20)13-7-5-12(11-19)6-8-13/h1-8,11H,9-10H2,(H,18,20)
InChIKey
KVKGNWNKUGUSFR-UHFFFAOYSA-N
Shipping
Room temperature

N-(2-(2-Fluorophenoxy)ethyl)-4-Formylbenzamide, a compound of notable interest, has been increasingly explored for its potential applications in the pharmaceutical industry. This chemical entity is often examined in the context of drug development due to its structural features, which may facilitate interactions with specific biological targets. The presence of the formyl group alongside the fluoro-substituted phenoxy moiety suggests potential utility in the synthesis of bioactive molecules, where modifications in such structures can lead to variations in activity or selectivity against certain biological pathways. Through these studies, researchers aim to uncover new therapeutic avenues, especially in challenging diseases that require more effective intervention strategies.

Furthermore, the compound's ability to influence interactions at the molecular level makes it an attractive candidate in medicinal chemistry research. Scientists focus on the compound’s role as a building block in constructing novel pharmacophores, which are parts of molecules responsible for their biological activity. By tweaking its structure, researchers can systematically evaluate changes in biological activity, offering insights into the relationships between chemical structure and biological function. This is particularly valuable in designing selective agents that can modulate specific proteins or enzymes implicated in disease processes, thereby advancing the development of more precise and targeted therapies.

In the realm of chemical biology, N-(2-(2-Fluorophenoxy)ethyl)-4-Formylbenzamide might also serve as a probe or a scaffold for designing analytical tools. Its structural attributes allow it to be incorporated into larger molecular frameworks that can be used to explore complex biological environments. Such tools are essential for visualizing cellular processes or for identifying and validating new biological targets. Consequently, this enhances our understanding of cellular pathways and mechanisms at a molecular level, enabling researchers to devise better strategies for diagnostic or therapeutic purposes.

Lastly, the compound's versatile chemistry allows it to be utilized in a variety of synthetic methodologies, expanding its applicability beyond pharmaceuticals into fields such as materials science. Incorporating this compound into polymers or advanced materials could impart novel properties, potentially leading to innovative applications in electronics, coatings, or biocompatible materials. The ability to blend function with form is a driving force in material innovation, and N-(2-(2-Fluorophenoxy)ethyl)-4-Formylbenzamide presents exciting possibilities in this aspect, inviting multidisciplinary research efforts aimed at harnessing its full potential.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Linker Development Enzyme Cleavable Linker Cathepsin B Cleavable Linker/Peptide Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker Sulfatase Cleavable Linker Chemically Cleavable Linker Non-Cleavable Linker Services Acid Cleavable Linker/Hydrazone Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Linkers - A Crucial Factor in Antibody–Drug Conjugates In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress New Structural Insights Solve Instability Issues of Maleimide Linkers in ADCs PEG Linkers in Antibody-Drug Conjugates Peptide Linkers in Antibody-Drug Conjugates Disulfide Linkers in Antibody-Drug Conjugates Biotinylation Reagents in Antibody-Drug Conjugates Maleimide Linkers in Antibody-Drug Conjugates Current ADC Linker Chemistry SPDB Linkers in Antibody-Drug Conjugates

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: Methyltetrazine-PEG4-oxyamine | sulfo-LC-SPDP | N-Boc-N-bis(PEG4-OH) | 2,5-dioxopyrrolidin-1-yl 3-(2-(2-undec-10-ynamidoethoxy)ethoxy)propanoate | 2,5-Dioxopyrrolidin-1-yl 3-((2,4-Difluorobenzyl)oxy)propanoate | succimimidyl-4-azidobutyrate | 2,5-Dioxopyrrolidin-1-yl 4-((2-(1,3-Dioxoisoindolin-2-Yl)ethyl)disulfanyl)butanoate | 2,5-Dioxopyrrolidin-1-yl 3-(benzyloxy)propanoate | Triptolide | Fmoc-N-amido-PEG3-propionic acid | N-(2-(2-Fluorophenoxy)ethyl)-4-Formylbenzamide
Send Inquiry
Verification code
Inquiry Basket